More Americans Lack a Consistent Source of Health Care
Drug Topics
NOVEMBER 17, 2022
Health disparities in care were made worse by the pandemic.
Thu.Nov 17, 2022
529 
4 pioneering social media campaigns in pharma this year
PharmaVoice
NOVEMBER 17, 2022
The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Gay Men Twice as Likely to Develop IBD
Drug Topics
NOVEMBER 17, 2022
New research indicates that gay men are at increased risk of inflammatory bowel disease.
Is AI just hype or a real revolution in pharma? It’s complicated
PharmaVoice
NOVEMBER 17, 2022
Artificial intelligence can be a useful tool and will likely augment many processes in biopharma — but it's still early days, and hype is rampant.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
What's the Buzz in Atopic Dermatitis?
Drug Topics
NOVEMBER 17, 2022
Experts discuss game-changing drugs and what’s in the pipeline.
Medicare Part D open enrollment and what recent changes mean for beneficiaries
PhRMA
NOVEMBER 17, 2022
It’s that time of year again: Medicare open enrollment ! Seniors and people with disabilities who are newly eligible for Medicare, as well as current Medicare beneficiaries, can select or update their Part D prescription drug plans for 2023 through Wednesday, December 7. Part D beneficiaries have a variety of plans to choose from, ranging from 24 to 32 options in each state.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Five Tips for a Successful Transition From the Third to Fourth Year of Pharmacy School
Pharmacy Times
NOVEMBER 17, 2022
Students should ask questions and stay engaged in their education.
Pharmacists are a Resource for Patients
Drug Topics
NOVEMBER 17, 2022
Drs Meece and Goldman share final thoughts on the overall current and future treatment landscape for diabetes.
Diet High in Sugar May Accelerate Aging in Survivors of Childhood Cancer
Pharmacy Times
NOVEMBER 17, 2022
Sugar…may not always be sweet. Survivors of childhood cancer have a risk of accelerated aging with every 25 grams of sugar consumed, according to researchers.
User Fees Reauthorized for FDA
Drug Topics
NOVEMBER 17, 2022
FDA keeps its user fees but fails to gain important reforms.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Editas, facing another setback, halts development on first clinical CRISPR program
STAT
NOVEMBER 17, 2022
Editas Medicine, one of the small handful of original CRISPR companies, announced Thursday it is halting development on its first clinical program after data showed only a small subset of patients were responding. Edit-101, an experimental CRISPR-based treatment for a rare eye disease called CEP290-meditated LCA10, led to “clinically meaningful” improvements in sight in only three out of 14 patients treated in the company’s Phase I study.
Ensuring Proper Injection Technique and Handling
Drug Topics
NOVEMBER 17, 2022
Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, discusses topics to address with patients to ensure appropriate self-administration of insulin.
Repeat COVID-19 infection deadlier than the first go-round, says study
Fierce Healthcare
NOVEMBER 17, 2022
Repeat COVID-19 infection deadlier than the first go-round, says study. fdiamond. Thu, 11/17/2022 - 10:38.
Optimizing Usage of Insulin Pens and Strategies to Educate Patients
Drug Topics
NOVEMBER 17, 2022
Experts provide suggestions for optimizing patient education by encouraging patient engagement.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Study: Nose Swabs Show Promise in Predicting Severity of RSV Hospitalization for Infants
Pharmacy Times
NOVEMBER 17, 2022
Investigators find that despite the same quantity of respiratory syncytial virus and presentation, some of the samples demonstrated signs of greater damage to cells.
Overcoming Fears of Injections
Drug Topics
NOVEMBER 17, 2022
Segment Description: Addressing fears surrounding insulin injections through education may positively impact treatment adherence.
Suboptimal Sleep Associated with Elevated Risk of Developing a Chronic Disease
Pharmacy Times
NOVEMBER 17, 2022
Five hours or less hours of sleep per night at 50 years of age was associated with a 25% higher risk of mortality over 25 years of follow-up.
In armadillos, leprosy expands healthy liver tissue. Could that tell us something about regenerating our own?
STAT
NOVEMBER 17, 2022
The mystery started with some skin samples. Anura Rambukkana was a Ph.D. student in Amsterdam, analyzing biopsies from migrants with Hansen’s disease, or leprosy. The illness could be painful and disfiguring, but in the lab, the infected cells didn’t look sickly. To Rambukkana’s eye, they seemed to be doing great. He noticed the same thing with nerve cells from mice.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Study Shows Medicare is the Least Accepted Form of Payment at Substance Use Disorder Treatment Facilities
Pharmacy Times
NOVEMBER 17, 2022
There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.
Meeting MSL training needs in an evolving landscape
pharmaphorum
NOVEMBER 17, 2022
As medical treatments become more complex, the role of the Medical Science Liaison (MSL) has never been more important. Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. But who keeps the MSLs up-to-date, and who makes sure they have the hard and soft skills necessary to be an effective partner for healthcare professionals?
UnitedHealthcare, AARP team up to lower the cost of hearing aids
Fierce Healthcare
NOVEMBER 17, 2022
UnitedHealthcare, AARP team up to lower the cost of hearing aids. hlandi. Thu, 11/17/2022 - 22:13.
DSN's Top Women in Health, Wellness & Beauty 2022 award winners
Drug Store News
NOVEMBER 17, 2022
Drug Store News celebrates the women making their mark in retail pharmacy with the fourth annual awards program.
Edible sensor delivers real-time antiretroviral dosage data
European Pharmaceutical Review
NOVEMBER 17, 2022
An innovative ingestible sensor technology tested in an interventional clinical trial provided HIV patients with real-time antiretroviral dosage data , enabling them to better control their infection. The drug regimen for 130 HIV patients was monitored by the Proteus Digital Health Feedback (PDHF) Information Technology system, which let patients know in real-time when a dose of medication had been taken.
Primary care physician burnout raging across the US and other high-income countries, Commonwealth Fund finds
Fierce Healthcare
NOVEMBER 17, 2022
Primary care physician burnout raging across the US and other high-income countries, Commonwealth Fund finds. dmuoio. Thu, 11/17/2022 - 13:03.
NICE recommends new treatment for EGFR-positive lung cancer
European Pharmaceutical Review
NOVEMBER 17, 2022
Final draft guidance published by the National Institute for Health and Care Excellence (NICE), recommends Mobocertinib (Exkivity), a new therapy that helps slow cancer growth in adults with epidermal growth factor receptor ( EGFR ) exon 20+ non-small-cell lung cancer (NSCLC), who have already received platinum-based chemotherapy. The treatment , produced by Takeda helps to addresses a clear unmet clinical need, as there is currently no standard treatment for the disease.
HLTH22: Private equity rebuffs critics, says it brings rigor, scale and necessary change to healthcare
Fierce Healthcare
NOVEMBER 17, 2022
HLTH22: Private equity rebuffs critics, says it brings rigor, scale and necessary change to healthcare. dmuoio. Thu, 11/17/2022 - 17:57.
NICE to update endometriosis guidelines to improve diagnosis and surgical management
Pharmaceutical Technology
NOVEMBER 17, 2022
The National Institute of Health and Care Excellence (NICE) has agreed to update its guidelines on endometriosis diagnosis, surgical management, and surgical management when fertility is a priority. The decision came following a surveillance review led by NICE, which identified sufficient new evidence to support this update. This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike.
Milliman: Home benefits surge in popularity among Medicare Advantage plans
Fierce Healthcare
NOVEMBER 17, 2022
Milliman: Home benefits surge in popularity among Medicare Advantage plans. rking. Thu, 11/17/2022 - 15:17.
Hershey goes big for the holiday season
Drug Store News
NOVEMBER 17, 2022
The brand is bringing back several seasonal products and launching its new Hershey’s Milk Chocolate Hot Chocolate Bombs.
Immunization Injection Injury Occurs at Pharmacy
Pharmacy Times
NOVEMBER 17, 2022
Importance of clear and accurate documentation is emphasized in patient claim for compensation.
The Ultimate Guide To Using Enzymes with Hashimoto’s
The Thyroid Pharmacist
NOVEMBER 17, 2022
“Bad digestion is at the root of all evil,” said Hippocrates, the ancient Greek physician who is considered to be the father of modern medicine. Although he was born in 460 BC, I think he was onto something! In the world of functional medicine, we often refer to this concept that all disease (and thereby all healing) begins in the gut. The gut performs the all-important role of digesting and absorbing the nutrients we take in.
DNA May Age More Quickly in Patients With Cancer Who Are HIV-positive
Pharmacy Times
NOVEMBER 17, 2022
Changes in DNA methylation may lead to accelerated aging in patients with cancer and HIV.
STAT+: ‘We were right all along:’ For Japanese drugmaker Eisai, success against Alzheimer’s has been a long time coming
STAT
NOVEMBER 17, 2022
NUTLEY, N.J. — A once-in-a-generation medicine was built on more than two decades of regret. In 1997, Eisai launched Aricept, a revolutionary treatment for the symptoms of Alzheimer’s disease, invented and developed by the company’s scientists in Japan. The arrival of the drug was a galvanizing moment for Eisai — a blockbuster product for a company on the rise and the first of what was expected to be a string of medicines to slow or even reverse the effects of the dis
Let's personalize your content